The therapy set at that moment was a combination of Capecitabine (1000 mg/m2 bid per os), deep radiofrequency oncological hyperthermia (Oncotherm EHY-3010 ML device) twice a week for one hour without rest and three hours whole-body infrared hyperthermia (Heckel HT 3000 device) for five consecutive days for a month.
The disease went into complete remission. The patient gained his weight by eight kg, had good and has continued appetite, with significantly improved quality of life. A CT scan documented the remission with contrast. The therapy continued for eighteen months with persistent remission. After eighteen months, a resurgence of the disease occurred, which proved intractable and led to death after three months.
The case report presented describes an unusual and very favorable clinical history. This had remarkable success with this protocol without using invasive surgical or laparoscopic HIPEC application. This case report may suggest a new approach to peritoneal disseminated cancer pathology and indeed may be the starting point to investigate further the effectiveness of this complex therapy protocol in other tumors with peritoneal dissemination.
Article Reference link: click here
Scientific article publishing date : 01/04/2021
Immucura identifier :BSC21_069EN